Infectious complications of urologic surgery

Complications of Urologic Surgery and Practice: Diagnosis, Prevention, and Management

Volumn , Issue , 2007, Pages 1-16

  Dall'Era, Marc A ^a   Walsh, Thomas J ^a   Krieger, John N ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876899550     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (96)

1. Kunin CM. Guidelines for urinary tract infections. Rationale for a separate strata for patients with "low-count" bacteriuria. Infection 1994; 22(suppl. 1):S38-S40, discussion S1.
2. Stamm WE. Urinary tract infections. Infect Dis Clin North Am 2003; 17:xiii-xiv.
3. Kunin CM. Definition of acute pyelonephritis vs the urosepsis syndrome. Arch Intern Med 2003; 163:2393, author reply, 4.
4. Krieger JN. Urinary tract infections: what's new? J Urol 2002; 168:2351-2358.
5. Kunin CM. Nosocomial urinary tract infections and the indwelling catheter: what is new and what is true? Chest 2001; 120:10-12.
6. Grabe M. Perioperative antibiotic prophylaxis in urology. Curr Opin Urol 2001; 11:81-85.
7. Kraklau DM, Wolf JS, Jr. Review of antibiotic prophylaxis recommendations for office-based urologic procedures. Tech Urol 1999; 5:123-128.
8. Rane A, Cahill D, Saleemi A, Montgomery B, Palfrey E. The issue of prophylactic antibiotics prior to flexible cystoscopy. Eur Urol 2001; 39:212-214.
9. Kortmann BB, Sonke GS, D'Ancona FC, Floratos DL, Debruyne FM, De La Rosette JJ. The tolerability of urodynamic studies and flexible cysto-urethroscopy used in the assessment of men with lower urinary tract symptoms. BJU Int 1999; 84:449-453.
10. Manson AL. Is antibiotic administration indicated after outpatient cystoscopy. J Urol 1988; 140: 316-317.
11. Puppo P, Ricciotti G, Bozzo W, Introini C. Primary endoscopic treatment of ureteric calculi. A review of 378 cases. Eur Urol 1999; 36:48-52.
12. Rao PN, Dube DA, Weightman NC, Oppenheim BA, Morris J. Prediction of septicemia following endourological manipulation for stones in the upper urinary tract. J Urol 1991; 146:955-960.
13. Hendrikx AJ, Strijbos WE, de Knijff DW, Kums JJ, Doesburg WH, Lemmens WA. Treatment for extended-mid and distal ureteral stones: SWL or ureteroscopy? Results of a multicenter study. J Endourol 1999; 13:727-733.
14. Knopf HJ, Graff HJ, Schulze H. Perioperative antibiotic prophylaxis in ureteroscopic stone removal. Eur Urol 2003; 44:115-118.
15. O'Keeffe NK, Mortimer AJ, Sambrook PA, Rao PN. Severe sepsis following percutaneous or endoscopic procedures for urinary tract stones. Br J Urol 1993; 72:277-283.
16. Mariappan P, Smith G, Bariol SV, Moussa SA, Tolley DA. Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol 2005; 173:1610-1614.
17. Childs SJ. Appropriate surgical prophylaxis in transurethral genitourinary surgery and potential reduction in nosocomial infections. Urology 1986; 27:15-20.
18. Berry A, Barratt A. Prophylatic antibiotic use in transurethral prostatic resection: a meta-analysis. J Urol 2002; 167(2 Pt 1):571-577.
19. Colau A, Lucet JC, Rufat P, Botto H, Benoit G, Jardin A. Incidence and risk factors of bacteriuria after transurethral resection of the prostate. Eur Urol 2001; 39:272-276.
20. Qiang W, Jianchen W, MacDonald R, Monga M, Wilt TJ. Antibiotic prophylaxis for transurethral prostatic resection in men with preoperative urine containing less than 100,000 bacteria per ml: a systematic review. J Urol 2005; 173:1175-1181.
21. Raz R, Almog D, Elhanan G, Shental J. The use of ceftriaxone in the prevention of urinary tract infection in patients undergoing transurethral resection of the prostate (TUR-P). Infection 1994; 22:347-349.
22. Badenoch DF, Murdoch DA, Tiptaft RC. Microbiological study of bladder tumors, their histology and infective complications. Urology 1990; 35:5-8.
23. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989; 142:71-74, discussion 4-5.
24. Aron M, Rajeev TP, Gupta NP. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int 2000; 85:682-685.
25. Griffith BC, Morey AF, Ali-Khan MM, Canby-Hagino E, Foley JP, Rozanski TA. Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk. J Urol 2002; 168:1021-1023.
26. Kapoor DA, Klimberg IW, Malek GH, et al. Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 1998; 52:552-558.
27. Enlund AL, Varenhorst E. Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy. A prospective study in 415 cases. Br J Urol 1997; 79:777-780.
28. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1997; 277:1794-1801.
29. Antibiotic prophylaxis for urological patients with total joint replacements. J Urol 2003; 169:1796-1797.
30. Carey JM, Korman HJ. Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications? J Urol 2001; 166:82-85.
31. Lindert KA, Kabalin JN, Terris MK. Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol 2000; 164:76-80.
32. Townsend CM. Sabiston Textbook of Surgery. 17th ed. St. Louis, Mosby: Saunders, 2004.
33. National Nosocomial Infections Surveillance (NNIS) System Report. Data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-485.
34. Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999; 20:725-730.
35. www.cdc.gov/NCIDOD/dhqp/gl-surgicalsite.html
36. Culver DH, Horan TC, Gaynes RP, et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med 1991; 91:152S-157S.
37. Gaynes RP, Culver DH, Horan TC, Edwards JR, Richards C, Tolson JS. Surgical site infection (SSI) rates in the United States, 1992-1998: the National Nosocomial Infections Surveillance System basic SSI risk index. Clin Infect Dis 2001; 33(suppl 2):S69-S77.
38. Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 1996; 334:1209-1215.
39. Belda FJ, Aguilera L, Garcia de la Asuncion J, et al. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA 2005; 294:2035-2042.
40. Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract 2004; 10(suppl 2):46-52.
41. Heinzelmann M, Scott M, Lam T. Factors predisposing to bacterial invasion and infection. Am J Surg 2002; 183:179-190.
42. Fuenfer MM, Olson GE, Polk HC, Jr. Effect of various corticosteroids upon the phagocytic bactericidal activity of neutrophils. Surgery 1975; 78:27-33.
43. Asensio A, Ramos A, Munez E, Vilanova JL, Torrijos P, Garcia FJ. Preoperative low molecular weight heparin as venous thromboembolism prophylaxis in patients at risk for prosthetic infection after knee arthroplasty. Infect Control Hosp Epidemiol 2005; 26:903-909.
44. Alexander JW, Fischer JE, Boyajian M, Palmquist J, Morris MJ. The influence of hair-removal methods on wound infections. Arch Surg 1983; 118:347-352.
45. Raves JJ, Slifkin M, Diamond DL. A bacteriologic study comparing closed suction and simple conduit drainage. Am J Surg 1984; 148:618-620.
46. Furuno JP, Perencevich EN, Johnson JA, et al. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci co-colonization. Emerg Infect Dis 2005; 11:1539-1544.
47. Weiss CA III, Statz CL, Dahms RA, Remucal MJ, Dunn DL, Beilman GJ. Six years of surgical wound infection surveillance at a tertiary care center: review of the microbiologic and epidemiological aspects of 20,007 wounds. Arch Surg 1999; 134:1041-1048.
48. Christou NV, Nohr CW, Meakins JL. Assessing operative site infection in surgical patients. Arch Surg 1987; 122:165-169.
49. Falcoz PE, Laluc F, Toubin MM, et al. Usefulness of procalcitonin in the early detection of infection after thoracic surgery. Eur J Cardiothorac Surg 2005; 27:1074-1078.
50. Tegnell A, Aren C, Ohman L. Wound infections after cardiac surgery-a wound scoring system may improve early detection. Scand Cardiovasc J 2002; 36:60-64.
51. Noone TC, Semelka RC, Worawattanakul S, Marcos HB. Intraperitoneal abscesses: diagnostic accuracy of and appearances at MR imaging. Radiology 1998; 208:525-528.
52. Bydder GM, Kreel L. Computed tomography in the diagnosis of abdominal abscess. J Comput Tomogr 1980; 4:132-145.
53. Noone TC, Semelka RC, Chaney DM, Reinhold C. Abdominal imaging studies: comparison of diagnostic accuracies resulting from ultrasound, computed tomography, and magnetic resonance imaging in the same individual. Magn Reson Imaging 2004; 22:19-24.
54. Khurrum Baig M, Hua Zhao R, Batista O, et al. Percutaneous postoperative intra-abdominal abscess drainage after elective colorectal surgery. Tech Coloproctol 2002; 6:159-164.
55. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg 2005; 189:395-404.
56. Stone HH, Haney BB, Kolb LD, Geheber CE, Hooper CA. Prophylactic and preventive antibiotic therapy: timing, duration and economics. Ann Surg 1979; 189:691-699.
57. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992; 326:281-286.
58. Kiddoo DA, Wollin TA, Mador DR. A population based assessment of complications following outpatient hydrocelectomy and spermatocelectomy. J Urol 2004; 171(2 Pt 1):746-748.
59. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. Clin Infect Dis 1997; 25:1448-1458.
60. Onur R, Ozden M, Orhan I, Kalkan A, Semercioz A. Incidence of bacteraemia after urodynamic study. J Hosp Infect 2004; 57:241-244.
61. Sullivan NM, Sutter VL, Mims MM, Marsh VH, Finegold SM. Clinical aspects of bacteremia after manipulation of the genitourinary tract. J Infect Dis 1973; 127:49-55.
62. Venn SN, Greenwell TJ, Mundy AR. The long-term outcome of artificial urinary sphincters. J Urol 2000; 164(3 Pt 1):702-706, discussion 6-7.
63. Hajivassiliou CA. A review of the complications and results of implantation of the AMS artificial urinary sphincter. Eur Urol 1999; 35:36-44.
64. Petero VG, Jr, Diokno AC. Comparison of the long-term outcomes between incontinent men and women treated with artificial urinary sphincter. J Urol 2006; 175:605-609.
65. Martins FE, Boyd SD. Postoperative risk factors associated with artificial urinary sphincter infection-erosion. Br J Urol 1995; 75:354-358.
66. Bryan DE, Mulcahy JJ, Simmons GR. Salvage procedure for infected noneroded artificial urinary sphincters. J Urol 2002; 168:2464-2466.
67. Gomha MA, Boone TB. Artificial urinary sphincter for post-prostatectomy incontinence in men who had prior radiotherapy: a risk and outcome analysis. J Urol 2002; 167(2 Pt 1):591-596.
68. Miller EA, Mayo M, Kwan D, Mitchell M. Simultaneous augmentation cystoplasty and artificial urinary sphincter placement: infection rates and voiding mechanisms. J Urol 1998; 160(3 Pt 1):750-752, discussion 2-3.
69. Holmes NM, Kogan BA, Baskin LS. Placement of artificial urinary sphincter in children and simultaneous gastrocystoplasty. J Urol 2001; 165(6 Pt 2):2366-2368.
70. Catto JW, Natarajan V, Tophill PR. Simultaneous augmentation cystoplasty is associated with earlier rather than increased artificial urinary sphincter infection. J Urol 2005; 173:1237-1241.
71. Ganesan GS, Nguyen DH, Adams MC, et al. Lower urinary tract reconstruction using stomach and the artificial sphincter. J Urol 1993; 149:1107-1109.
72. Raj GV, Peterson AC, Toh KL, Webster GD. Outcomes following revisions and secondary implantation of the artificial urinary sphincter. J Urol 2005; 173:1242-1245.
73. Small MP. Small-carrion penile prosthesis: a report on 160 cases and review of the literature. J Urol 1978; 119:365-368.
74. Schwartz BF, Swanzy S, Thrasher JB. A randomized prospective comparison of antibiotic tissue levels in the corpora cavernosa of patients undergoing penile prosthesis implantation using gentamicin plus cefazolin versus an oral fluoroquinolone for prophylaxis. J Urol 1996; 156:991-994.
75. Montague DK, Jarow JP, Broderick GA, et al. Chapter 1: The management of erectile dysfunction: an AUA update. J Urol 2005; 174:230-239.
76. Carson CC III. Efficacy of antibiotic impregnation of inflatable penile prostheses in decreasing infection in original implants. J Urol 2004; 171:1611-1614.
77. Henry GD, Wilson SK, Delk JR II, et al. Revision washout decreases penile prosthesis infection in revision surgery: a multicenter study. J Urol 2005; 173:89-92.
78. Nickel JC, Heaton J, Morales A, Costerton JW. Bacterial biofilm in persistent penile prosthesis-associated infection. J Urol 1986; 135:586-588.
79. Silverstein A, Donatucci CF. Bacterial biofilms and implantable prosthetic devices. Int J Impot Res 2003; 15(suppl 5):S150-S154.
80. Henry GD, Wilson SK, Delk JR II, et al. Penile prosthesis cultures during revision surgery: a multicenter study. J Urol 2004; 172:153-156.
81. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004; 350: 1422-1429.
82. Mulcahy JJ. Long-term experience with salvage of infected penile implants. J Urol 2000; 163: 481-482.
83. Merrill DC. Clinical experience with the Mentor inflatable penile prosthesis in 301 patients. J Urol 1988; 140:1424-1427.
84. Kabalin JN, Kessler R. Infectious complications of penile prosthesis surgery. J Urol 1988; 139: 953-955.
85. Montague DK. Periprosthetic infections. J Urol 1987; 138:68-69.
86. Minervini A, Ralph DJ, Pryor JP. Outcome of penile prosthesis implantation for treating erectile dysfunction: experience with 504 procedures. BJU Int 2006; 97:129-133.
87. Carson CC, Robertson CN. Late hematogenous infection of penile prostheses. J Urol 1988; 139: 50-52.
88. Jarow JP. Risk factors for penile prosthetic infection. J Urol 1996; 156(2 Pt 1):402-404.
89. Kaufman JJ, Lindner A, Raz S. Complications of penile prosthesis surgery for impotence. J Urol 1982; 128:1192-1194.
90. Wilson SK, Delk JR II. Inflatable penile implant infection: predisposing factors and treatment suggestions. J Urol 1995; 153(3 Pt 1):659-661.
91. Buchholz HW, Elson RA, Engelbrecht E, Lodenkamper H, Rottger J, Siegel A. Management of deep infection of total hip replacement. J Bone Joint Surg Br 1981; 63-B:342-353.
92. Miley GB, Scheller AD Jr, Turner RH. Medical and surgical treatment of the septic hip with one-stage revision arthroplasty. Clin Orthop Relat Res 1982; 170:76-82.
93. Ure KJ, Amstutz HC, Nasser S, Schmalzried TP. Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up. J Bone Joint Surg Am 1998; 80:961-968.
94. Berbari EF, Osmon DR, Duffy MC, et al. Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes. Clin Infect Dis 2006; 42:216-223.
95. Mulcahy JJ, Brant MD, Ludlow JK. Management of infected penile implants. Tech Urol 1995; 1: 115-119.
96. Kaufman JM, Kaufman JL, Borges FD. Immediate salvage procedure for infected penile prosthesis. J Urol 1998; 159:816-818.